Invention Grant
US09260430B2 Use of TRPA1 antagonists to prevent or treat infections caused by biological-warfare agents
有权
使用TRPA1拮抗剂预防或治疗由生物战剂引起的感染
- Patent Title: Use of TRPA1 antagonists to prevent or treat infections caused by biological-warfare agents
- Patent Title (中): 使用TRPA1拮抗剂预防或治疗由生物战剂引起的感染
-
Application No.: US13702488Application Date: 2011-06-08
-
Publication No.: US09260430B2Publication Date: 2016-02-16
- Inventor: Magdalene M. Moran
- Applicant: Magdalene M. Moran
- Applicant Address: US MA Cambridge
- Assignee: HYDRA BIOSCIENCES, INC.
- Current Assignee: HYDRA BIOSCIENCES, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Lando & Anastasi LLP
- International Application: PCT/US2011/039604 WO 20110608
- International Announcement: WO2012/050641 WO 20120419
- Main IPC: A61K31/522
- IPC: A61K31/522 ; A61K31/52 ; C07D473/08 ; A61K31/65
Abstract:
Provided are methods for preventing and treating injuries caused by exposure to biological warfare agents. The methods include administering to a subject in need thereof an effective amount of a TRPA1 antagonist or a pharmaceutically acceptable salt thereof. In an embodiment the TRPA1 antagonist is selected from the group consisting of compounds of formula I and compounds of formula II as described herein.
Public/Granted literature
- US20130310345A1 Use of TRPA1 Antagonists to Prevent or Treat Infections Caused by Biological-Warfare Agents Public/Granted day:2013-11-21
Information query
IPC分类:
